好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Neuro-oncology Update II: Systemic Cancer

Friday 04/16/10
09:00 AM - 12:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
AM Half-Day Course
Lisa M. DeAngelis, MD, FAAN
Participants should be familiar with the differential diagnoses and treatment of brain metastases, leptomeningeal metastases, and vascular, metabolic, and paraneoplastic complications of cancer.
No CME available
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist
Didactic
Event Timeline
09:00 AM - 09:40 AM Brain Metastases
David Schiff, MD, FAAN
09:40 AM - 09:50 AM Questions and Answers
David Schiff, MD, FAAN
09:50 AM - 10:30 AM Leptomeningeal Metastases
Jennifer L. Clarke, MD, MPH
10:30 AM - 10:40 AM Questions and Answers
Jennifer L. Clarke, MD, MPH
10:40 AM - 11:00 AM Break
11:00 AM - 11:40 AM Paraneoplastic Syndromes
Josep O. Dalmau, MD, PhD, FAAN
11:40 AM - 11:50 AM Questions and Answers
Josep O. Dalmau, MD, PhD, FAAN
11:50 AM - 12:30 PM Vascular Disease in Cancer Patients
Lisa M. DeAngelis, MD, FAAN
12:30 PM - 12:40 PM Questions and Answers
Lisa M. DeAngelis, MD, FAAN
12:40 PM - 12:45 PM Discussion
Faculty Disclosures
Lisa M. DeAngelis, MD, FAAN Dr. DeAngelis has received publishing royalties from a publication relating to health care.
Josep O. Dalmau, MD, PhD, FAAN Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
David Schiff, MD, FAAN Dr. Schiff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Pharmaceutical. Dr. Schiff has received publishing royalties from a publication relating to health care.
Jennifer L. Clarke, MD, MPH The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. The institution of Dr. Clarke has received research support from Agios. The institution of Dr. Clarke has received research support from Servier. The institution of Dr. Clarke has received research support from Merck.